pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,354 catalysts · 3,183 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 76 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-29×clear all
type
  • 8k filing3,183
  • grant2,032
  • device adverse event1,000
  • approval910
  • device 510k674
  • earnings584
device pma
508
  • device recall215
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 9, 2026

    50
    ›Feb 9, 2026grant185d agoTEXAS A&M UNIVERSITY HEALTH SCIENCE CTR — A versatile bimodal QF/QS gene expression system for insect and vertebrate mo...

    AI grant. $416,894. PI: Hubert O Amrein

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoCINCINNATI CHILDRENS HOSP MED CTR — Patient-specific, combinatorial NAMs for gastrointestinal diseases and drug r...

    TR grant. $3,240,000. PI: LEE ARMISTEAD DENSON

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoFEDERATION OF AMER SOC FOR EXPER BIOLOGY — Phase Transitions in Cellular Signaling and Disease

    CA grant. $5,000. PI: Priya R. Banerjee

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoEAST CAROLINA UNIVERSITY — Determining how Yersinia pestis YbX and the competition for host zinc impact ...

    AI grant. $226,500. PI: Roger D Pechous

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Infection-induced cell cycle diversion promotes macrophage inflammatory bioge...

    AI grant. $186,758. PI: Mary O'Riordan

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoBOSTON UNIVERSITY MEDICAL CAMPUS — Mechanisms of the alternative macrophage activation in TB

    AI grant. $245,250. PI: Igor Kramnik

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoMASSACHUSETTS GENERAL HOSPITAL — Mechanistic intersection between placental vascular and newborn neuronal deve...Massachusetts General Hospital

    HD grant. $715,595. PI: Lisa M Bebell

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoMASSACHUSETTS GENERAL HOSPITAL — Mechanistic intersection between placental vascular and newborn neuronal deve...Massachusetts General Hospital

    HD grant. $36,131. PI: Lisa M Bebell

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoUNIVERSITY OF VIRGINIA — Host lipid acquisition and maintenance of the Chlamydia replicative nicheUniversity of Virginia

    AI grant. $717,952. PI: ISABELLE DERRE

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoOHIO STATE UNIVERSITY — Mechanisms of simian arterivirus entry, immune evasion, and zoonotic potential

    AI grant. $790,507. PI: Cody Jay Warren

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoDARTMOUTH-HITCHCOCK CLINIC — Multiplexed reporter platforms for probing the bile acid- nuclear receptor in...

    AI grant. $232,500. PI: Mark Scott Sundrud

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoMASSACHUSETTS GENERAL HOSPITAL — Decoding the neuroimmune control of cutaneous gamma/delta cell function in al...Massachusetts General Hospital

    AI grant. $776,034. PI: Caroline Lauren Sokol

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoUNIVERSITY OF WISCONSIN-MADISON — Multipronged approach to characterize the promiscuity and mechanism of PACE t...

    AI grant. $414,305. PI: Katherine Anne Henzler-Wildman

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Eliciting Th1/Th17 dual responses for vaccine-induced immunity to tuberculosis

    AI grant. $460,625. PI: Rocky Lai

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoOREGON HEALTH & SCIENCE UNIVERSITY — Identifying drug targets in M. abscessus through the application of fluoresce...

    AI grant. $442,758. PI: Kimberly Elizabeth Beatty

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoGORDON RESEARCH CONFERENCES — 2026 Thalamocortical Interactions Gordon Research Conference and Gordon Resea...

    NS grant. $15,000. PI: Solange P Brown

    full page →nih reporter ↗
    ›Feb 9, 2026grant185d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — RISE UP for Breast Cancer 2026University of California San Francisco

    CA grant. $12,500. PI: LAURA J ESSERMAN

    full page →nih reporter ↗
    ›Feb 10, 2026approval184d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →pembrolizumab →fda approvals ↗
    ›Feb 10, 2026approval184d agoKEYTRUDA QLEX (PEMBROLIZUMAB) — FDA approval(berahyaluronidase alfa + pembrolizumab)

    Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

    full page →(berahyaluronidase alfa + pembrolizumab) →fda approvals ↗
    ›Feb 10, 2026approval184d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval184d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Feb 10, 2026approval184d agoFLUDROCORTISONE ACETATE — FDA approvalNovitium Pharma LLC

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval184d agoTRETINOIN — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: ENCUBE. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 10, 2026approval184d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval184d agoFLUOROURACIL — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval184d agoSULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE) — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 10, 2026approval184d agoGLYCOPYRROLATE — FDA approvalGLYCOPYRROLATE

    Sponsor: RISING. Form: TABLET. Route: ORAL

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Feb 10, 2026approval184d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

    Sponsor: HIKMA. Form: TABLET. Route: ORAL

    full page →tapentadol hydrochloride ER →fda approvals ↗
    ›Feb 10, 2026device 510k184d agoK2m, Inc. — Vulcan Spinal System (510k cleared)

    Product code: NKB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoFresenius Medical Care Renal Therapies Group, LLC — multiFlux 130 (F00013123); multiFlux 160 (F00013124) (510k cleared)Fresenius Medical Care AG

    Product code: KDI. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoOvigenex, LLC — CollOvine™ Wound Powder (510k cleared)

    Product code: KGN. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoFourth Axis, LLC — LANDR Contact LENS Case (510k cleared)

    Product code: LRX. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoShenzhen RF Tech Co., Ltd. — GEM Flex Coil 16-L Array, 1.5T Receive Only; GEM Flex Coil 16-M Array, 1.5T Receive Only; GEM Flex Coil 16-S Array, 1.5T Receive Only (510k cleared)

    Product code: MOS. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoCreoDent Hudson Valley — Solidex® Ti-Links and Screws (510k cleared)

    Product code: NHA. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoMedtronic Xomed, Inc. — NIM Essence™ EMG Endotracheal Tube (NIMEID060); NIM Essence™ EMG Endotracheal Tube (NIMEID065); NIM Essence™ EMG Endotracheal Tube (NIMEID070); NIM Essence™ EMG Endotracheal Tube (NIMEID075); NIM Essence™ EMG Endotracheal Tube (NIMEID080) (510k cleared)Medtronic USA Inc

    Product code: ETN. Advisory committee: Ear, Nose, Throat. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoSiemens Medical Solutions USA, Inc. — MI View&GO (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoBiodynamik, Inc. — XT3 System; XT3 System, Mini; XT3 System, 40mm; XT3 System, Mini, 40mm (510k cleared)

    Product code: JDW. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoEarflo, Inc. — Earflo (EF001) (510k cleared)

    Product code: MJV. Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 10, 2026device 510k184d agoBoston Scientific Corporation — SpaceOAR Vue System (SV-2101) (510k cleared)BOSTON SCIENTIFIC CORP

    Product code: OVB. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Feb 10, 2026device pma184d agoMedtronic Cardiac Rhythm Disease Management — SelectSecure Lead (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic Cardiac Rhythm Disease Management — Amplia MRI CRT-D; Amplia MRI Quad CRT-D; Brava CRT-D; Brava Quad CRT-D; Claria MRI CRT-D; Claria MRI Quad CRT-D; Cobalt (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoAlcon Research, LLC — UNIPURE C3F8 Ophthalmic Gas in the UNIFEYE Gas Delivery System (PMA supplement)

    Supplement type: Real-Time Process. Product code: LPO. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Micra AV2 TPS; Micra VR2 TPS (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: PNJ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoAlcon Laboratories — VISCOAT™ Ophthalmic Viscosurgical Device (PMA supplement)Alcon Laboratories Inc

    Supplement type: Normal 180 Day Track. Product code: LZP. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Advisa DR IPG (A4DR01); Advisa DR MRI IPG (A2DR01); Advisa SR MRI IPG (A3SR01); Astra S DR MRI IPG (X3DR01); Astra S SR (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVZ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Harmony™ Transcatheter Pulmonary Valve (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoBoston Scientific Corporation — TheraSphere (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Panel Track. Product code: NAW. Advisory committee: RA. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoAgilent Technologies, Inc. — PD-L1 IHC 22C3 pharmDx (PMA supplement)AGILENT TECHNOLOGIES, INC.

    Supplement type: Panel Track. Product code: PLS. Advisory committee: PA. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic Cardiac Rhythm Disease Management — Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Aurora EV ICD DVEA3E4 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ← prev
    page 15 of 188
    next →
    $FMS23.70-0.71%
    $BSX51.55+0.70%
    $MDT90.02-0.73%
    $MDT90.02-0.73%
    $MDT90.02-0.73%
    $BSX51.55+0.70%
    $MDT90.02-0.73%
    $A148.55-0.63%